We hereby submit Notice of 5th AGM to be held on September 28, 2026.

Exporter & Trader of Speciality Medicines Date: 03/09/2026 BSE Limited. PJ Towers, Dalal Street, Mumbai – 400001 Sub: Submission of Notice of 5th Annual general meeting Reference: Speciality Medicines Limited (Id: SPML; Code: 544738) Pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, please find attached herewith Notice of 5th Annual General Meeting dated September 03, 2026 (“the Notice”) together with the Explanatory Statement seeking approval of the members of the Company for resolutions as set out in the notice, in respect of 5th Annual General Meeting of the Members of Speciality Medicines Limited (“the Company”) to be held on Monday, September 28, 2026 at 11:00 A.M. IST through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”). The Notice is being sent only through electronic mode to the members whose names appear in the Register of Members / List of Beneficial Owners as received from National Securities Depository Limited and Central Depository Services (India) Limited and whose email id is registered with the Company/Depositories, as on Friday, August 28, 2026. The Company has engaged the services of National Securities Depository Limited (“NSDL”), for providing remote e-voting facility to all members. The e-voting facility will be available during the following period: Commencement of e-voting: 9:00 a.m. (IST) on Friday, September 25, 2026 End of e-voting: 5:00 p.m. (IST) on Sunday, September 27, 2026. The Notice is also available on the Company's website at www.specialitymedicine.com. The facility for voting through electronic voting system shall also be made available during the AGM and the Members attending the AGM and holding shares as on the cut-off date being the day of Monday, September 21, 2026 and who have not already cast their vote by remote e-voting, shall be able to exercise their right to vote at the AGM. Request you to please take the same on your records. Thanking you, Yours Faithfully, For, SPECIALITY MEDICINES LIMITED (Formerly Known as Speciality Medicines Private Limited) SUMIT GOYANI Whole-Time Director DIN: 07885780 Place: Mumbai SPECIALITY MEDICINES LIMITED (Formerly Known as Speciality Medicines Private Limited) CIN: L85300GJ2021PLC120022 Corp. Office : Unit 27, Ground Floor, Andheri Sainath Premises Co Soc, 20 Mahakali Caves Road, Andheri (East), Mumbai, Maharashtra, India, 400093 Regd. Office : 913, One World West, S. No. 396, FP 119, Village- Vejalpur, Ahmedabad 380051, Gujarat, India +91 99242 03751 / 99242 43751 info@specialitymedicine.com www.specialitymedicine.com CORPORATE OVERVIEW STATUTORY REPORTS FINANCIAL STATEMENTS NOTICE OF AGM NOTICE OF 5th ANNUAL GENERAL MEETING Notice is hereby given that the 5th Annual General Registered office: Meeting of the members Speciality Medicines Limited 913, One World West, S. No. 396, FP 119, Village- (Formerly Known as Speciality Medicines Private Vejalpur, Ahmadabad City, Ahmedabad, Gujarat, India, Limited) will be held on Monday, September 28, 2026 at 380051. 11:00 AM through Video Conferencing (“VC”) / Other Audio-Visual Means (“OAVM”) to transact the following IMPORTANT NOTES: businesses: 1. The Ministry of Corporate Affairs (“MCA”) permitted ORDINARY BUSINESSES: holding of the AGM through VC/OAVM, without physical presence of the Members at a common Item No. 1 venue. In compliance with the MCA Circulars, AGM To consider and adopt the audited financial of the Company is being held through VC/OAVM. statement of the Company for the financial year The Registered Office of the Company shall be ended March 31, 2026 and the reports of the Board deemed to be the venue for the AGM. [General of Directors and Auditors thereon. Circular Nos. 14/2020 dated April 8, 2020 and To consider and if thought fit, to pass, with or without 17/2020 dated April 13, 2020, in relation to modification(s), the following resolutions as Ordinary “Clarification on passing of ordinary and special Resolutions. resolutions by companies under the Companies Act, “RESOLVED THAT the audited financial statement of 2013”, General Circular Nos. 20/2020 dated May 5, the Company for the financial year ended March 31, 2020 and subsequent circulars issued in this regard, 2026 and the reports of the Board of Directors and the latest being 09/2024 dated September 19, 2024 Auditors thereon, as circulated to the members, be and and General Circular No. 03/2025 dated September are hereby considered and adopted.” 22, 2025 prescribing the procedures and manner of conducting the Annual General Meeting through VC/ Item No. 2 OAVM. In terms of the said circulars, the Annual To appoint a Director in place of Mr. Sumit Babubhai General Meeting (AGM) of the members will be held Goyani (DIN 07885780), who retires by rotation and through VC/OAVM. Hence, members can attend being eligible, seeks re-appointment. and participate in the AGM through VC/OAVM only. Explanation: Based on the terms of appointment, Hence, members can attend and participate in the executive and non-executive directors are subject to AGM through VC/OAVM only. retirement by rotation. Mr. Sumit Babubhai Goyani (DIN The detailed procedure for participation in the 07885780), who was appointed as Whole-Time Director meeting through VC/OAVM is as per note no. 15 and for the current term, and is the longest-serving member available at the Company’s website on the Board, retires by rotation and, being eligible, www.specialitymedicine.com. The deemed venue seeks re-appointment. for the AGM shall be the Registered Office of the To the extent that Mr. Sumit Babubhai Goyani (DIN Company. 07885780) is required to retire by rotation, he would 2. The relevant details, pursuant to Regulations 36(3) need to be reappointed as such. Therefore, of the Securities and Exchange Board of India shareholders are requested to consider and if thought fit, (Listing Obligations and Disclosure Requirements) to pass, with or without modification(s), the following Regulations, 2015 (“SEBI Listing Regulations”) and resolution as an Ordinary Resolution: Secretarial Standard II on General Meetings issued “RESOLVED THAT, pursuant to the provisions of by the Institute of Company Secretaries of India, in Section 152 and other applicable provisions of the respect of Directors seeking re-appointment at this Companies Act, 2013, the approval of the members of Annual General Meeting (“AGM”) is also annexed. the Company be and is hereby accorded for the 3. Though, pursuant to the provisions of the Act, a reappointment of Mr. Sumit Babubhai Goyani (DIN Member is entitled to attend and vote at the AGM is 07885780) as such, to the extent that he is required to entitled to appoint a proxy to attend and vote on retire by rotation.” his/her behalf, since this AGM is being held pursuant By order of the Board of Directors to the Circular No. 14/2020 dated April 8, 2020, For, SPECIALITY MEDICINES LIMITED issued by the Ministry of Corporate Affairs, the CIN: L85300GJ2021PLC120022 facility to appoint proxy to attend and cast vote for the members is not available for this AGM and hence the Proxy Form and Attendance Slip are not annexed to this Notice. 4. The attendance of the Members attending the AGM Place: Mumbai Parthkumar Goyani through VC/OAVM will be counted for the purpose Date: September Chairman & Managing Director of reckoning the quorum under Section 103 of the 03, 2026 DIN: 07885789 Companies Act, 2013. SPECIALITY MEDICINES LIMITED | 73 5. Since the AGM will be held through VC/OAVM, the dormant for long period of time. Periodic statement route map of the venue of the Meeting is not of holdings should be obtained from the concerned annexed hereto. Depository Participant and holdings should be verified. 6. Institutional/Corporate Shareholders (i.e. other than individuals/HUF, NRI, etc.) are required to 12. The Register of Directors and Key Managerial send a scanned copy (PDF/JPEG Format) of its Personnel and their shareholding, mai [Showing first 8,000 characters — download PDF for full document]